Search Videos and More
News
Case Study: ICU-Based Chemotherapy for High-Risk Cardiac DLBCL Patient
A 34-year-old woman with newly diagnosed mediastinal diffuse large B-cell lymphoma developed alarming cardiac symptoms during her initial hospitalization.
News
Temple Lung Center | Enrolling Clinical Trials
The Temple Lung Center conducts one of the most comprehensive lung disease clinical trials programs in the country. Our advancements in basic, translational and clinical research are changing lung disease treatment. By pioneering effective therapies, we bring hope to patients with serious and debilitating lung diseases.
News
Temple Sets New National Record in Lung Transplant
The Temple Lung Center is one of the most active and experienced lung transplant programs in the world - and a national destination for complex, high-risk patients.
News
2026 GOLD Report: A Landmark Revision Shaping the Future of COPD Management
The Temple Lung Center continues to play a defining role in advancing the global standard of care for patients with chronic obstructive pulmonary disease (COPD). As a contributor to the international dialogue on evidence-based best practices, the Temple Lung Center not only helped support the development of the 2026 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report, but also played a role in shaping discussions at the 2025 GOLD Conference—where global experts convened to preview evolving evidence and clinical trends, as well as review updates to the standard of care for COPD patients.
News
EMR-Integrated Tool Identifies PAH Candidates Missed by Standard Referral Pathways
Pulmonary arterial hypertension is a life-threatening form of right heart failure, with poor survival when treatment is delayed. Unfortunately, because PAH has vague symptoms like shortness of breath and requires invasive testing, it typically takes 2.8 years for patients to be accurately diagnosed.
News
Temple Lung Center Performs First U.S. BREATHE-3 Procedure for Severe Emphysema
The Phase-3 trial of Apreo Health’s bronchoscopic airway scaffold for severe emphysema and hyperinflation is now enrolling at the Temple Lung Center.
Course
AI-Powered LDCT: Temple Establishes New Paradigm for Lung Disease Detection
Pulmonologists are at the forefront of detecting and managing lung disease - and now, artificial intelligence (AI) is redefining what’s possible in early detection and workflow efficiency. The Temple Lung Center has become the first pulmonary program in the nation to integrate AI into routine lung screening, using AI software as a core diagnostic tool that supports early detection, multidisciplinary review, and streamlined patient care pathways.
Course
Advanced Heart Failure Therapies: Who, When, & What
Of the more than 6 million Americans living with heart failure, approximately 10% have advanced heart failure or Stage D Heart Failure. Patients in this category should be evaluated for advanced therapy options including heart transplant and LVAD therapy. This educational activity will focus on the identification of patients with Stage D Heart Failure utilizing basic variables from history, lab data, imaging, physical exam, and current regimen.
News
Case Study: EV-ICD and Epicardial Ablation in a 40-Year-Old Patient
A 40-year-old man presented with palpitations and dizziness that had been ongoing for several days. EMS found that he was in sustained monomorphic ventricular tachycardia and performed cardioversion to restore regular heart rhythm. In conversation with care providers, the patient recalled a prior episode of chest pain that had lasted for several days. He was brought to Temple Health for further care.
Course
Devices Can Play a Key Role in Managing Heart Failure
Even with gold-standard treatment, heart failure causes tremendous distress in patients, with debilitating symptoms and pain that can impact their day-to-day functioning, social relationships, and mental health. Studies have found that the quality of life for heart failure patients is comparable to people on dialysis, and five-year survival estimates are on par with some cancers.
News
Temple Lung Center: Advancing Research in ILD
Interstitial lung diseases (ILD) significantly impact patient morbidity and mortality. As an ILD Center of Excellence, the Temple Lung Center has established comprehensive programs for the evaluation and management of patients with a wide range of ILDs. This includes extensive clinical research and lung transplantation expertise.
Course
Complex Patient Case Review for Oncologic and Benign Urology
Live Webinar | 5:00 PM - 6:00 PM EDT | Wednesday, May 21, 2025